Plant Extracts in Nanomedicine: From Formulation to Therapeutic Application
A special issue of Plants (ISSN 2223-7747). This special issue belongs to the section "Phytochemistry".
Deadline for manuscript submissions: 31 July 2026 | Viewed by 54
Special Issue Editors
Interests: redox homeostasis; biostimulation; cell signaling; biological activity of phytopharmaceuticals; immunomodulation
Interests: biological activity of nutraceuticals; pharmacological effects; oxidative stress; cell migration; nanocarriers for delivery of biomolecules
Interests: phytochemistry; natural products chemistry; green nanotechnology; traditional medicine
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Plant extracts hold essential importance in the advancement of phytotherapeutic products and serve as a crucial global resource for health care. Natural products derived from these plants offer greater advantages when compared to synthetic alternatives. Their secondary metabolites demonstrate a wide range of biological activities, including anticancer, antiviral, antimicrobial, antioxidant, antihyperglycemic, anti-inflammatory, and antiseptic effects, both in vitro and in vivo. Importantly, these activities often arise from multifaceted mechanisms of action, highlighting the unique therapeutic potential of plant-derived compounds. As such, many medicinal plants show potential for addressing a variety of health disorders.
Pharmacological studies of plant extracts and nanoparticles have emerged as a promising research area, combining the therapeutic potential of plant-derived bioactive compounds with the unique properties of nanomaterials. Plant extracts, rich in diverse secondary metabolites, hold promise for treating a range of diseases, while nanoparticles, with their enhanced bioavailability and targeted delivery capabilities, offer innovative ways to improve the efficacy of these plant-based compounds.
This Special Issue will highlight advances in the pharmacological applications of plant-based nanoparticles. Particular attention will be given to the green synthesis of nanoparticles using plant extracts, where phytochemicals act as reducing and stabilizing agents and simultaneously enrich the nanoparticles with bioactive components. These biofunctionalized nanomaterials, together with nanoparticle-based delivery systems designed for plant-derived compounds, represent a promising strategy to enhance solubility, stability, bioavailability, and targeted therapeutic action. By merging phytochemistry and nanotechnology, this Special Issue aims to showcase innovative approaches that expand the pharmacological potential of medicinal plants.
The Special Issue “Plant Extracts in Nanomedicine: From Formulation to Therapeutic Application” seeks to explore the integration of plant extracts with nanoparticles for various applications, including:
- The development of nanoparticle-based delivery systems with plant bioactive compounds to enhance their pharmacological effects.
- Eco-friendly (green) synthesis methods using plant extracts, surface functionalization with bioactive metabolites, and innovative therapeutic applications.
- The use of nanoparticles in the formulation of plant-derived therapeutics with improved stability, solubility, and bioavailability.
We welcome original research articles, reviews, and short communications that explore innovative applications of plant extracts and nanoparticles across pharmacology, nanotechnology, and plant biology. Submissions that focus on the innovative use of plant extracts and nanoparticles, bridging the gap between pharmacology, nanotechnology, and plant sciences, are particularly encouraged.
Dr. Ana Obradovic
Dr. Miloš Matić
Prof. Dr. Ahmed Hussein
Dr. Nikola Srećković
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Plants is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- plant extracts
- nanoparticles
- bioactive compounds
- green synthesis
- pharmacological applications
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
